Natco Pharma Share Price Live blog for 20 Nov 2023
Natco Pharma stock price went up today, 20 Nov 2023, by 0.91 %. The stock closed at 773.2 per share. The stock is currently trading at 780.25 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news. Natco Pharma Share Price Live blog for 17 Nov 2023
Natco Pharma stock price went up today, 17 Nov 2023, by 2 %. The stock closed at 758.6 per share. The stock is currently trading at 773.75 per share. Investors should monitor Natco Pharma stock price closely in the coming days and weeks to see how it reacts to the news.
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of earnings conference call Q2 FY24 NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q2FY24 Results NATCO PHARMA LTD. - 524816 - Resignation Of Mr. Suresh Babu K - Vice President - QA - Chemical Division -Mekaguda Of The Company
Resignation of Mr. Suresh Babu K - Vice President - QA - Chemical Division - Mekaguda of the Company
Natco Pharma Results Earnings Call for Q2FY24
Conference Call with Natco Pharma Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript. NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Publications
Natco Pharma trades 2% lower even as its Q2 net profit zooms 550% YoY
The Natco Pharma stock has given a return of 26.22 percent over the last six months. The benchmark Nifty50 index has given a return of 5.68 percent over the same duration. NATCO PHARMA LTD. - 524816 - Record Date For Payment Of Second Interim Dividend For The FY2024
Record Date for payment of Second Interim Dividend for the FY2024 NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO Records Rs.1060.8 Crore consolidated revenue and Rs.369 Crore of Profit after tax, for the Second Quarter, FY2024